Related content

Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

By Kageyama Yasunori   Takahashi Masaaki   Torikai Eiji   Suzuki Motohiro   Ichikawa Tetsuya   Nagafusa Tetsuyuki   Koide Yukio   Nagano Akira  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 505-509

Springer Publishing Company

Access to resources Recommend Favorite

Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab

By Pieringer Herwig   Stuby Ulrike   Pohanka Erich   Biesenbach Georg  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 723-727

Springer Publishing Company

Access to resources Recommend Favorite

The serum concentration of infliximab in cases of autologous blood donation for patients with rheumatoid arthritis

By Mochizuki Takeshi   Momohara Shigeki   Ikari Katsunori   Okamoto Hiroshi   Kobayashi Shu   Tsukahara So   Iwamoto Takuji   Kawamura Koichiro   Saito Seiji   Tomatsu Taisuke  

Modern Rheumatology, Vol. 17, Iss. 1, 2007-02 ,pp. : 24-27

Springer Publishing Company

Access to resources Recommend Favorite

Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody

By Mori Shunsuke   Imamura Fumiya   Kiyofuji Chikage   Sugimoto Mineharu  

Modern Rheumatology, Vol. 16, Iss. 4, 2006-08 ,pp. : 251-255

Springer Publishing Company

Access to resources Recommend Favorite

A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab

By Kuroda Takeshi  

Rheumatology International, Vol. 28, Iss. 11, 2008-09 ,pp. : 1155-1159

Springer Publishing Company

Access to resources Recommend Favorite